CORONAVIRUS - 2020

[DDA]

KNOS PR

KRONOS ADVANCED TECHNOLOGIES INC ANNOUNCES EXCLUSIVE MANUFACTURING AND DISTRIBUTION AGREEMENT FOR A NEW LINE OF AIR DISINFECTION PRODUCTS

April 08, 2020 05:30 ET | Source: Kronos Advanced Technologies Inc.

Los Angeles , CA, April 08, 2020 (GLOBE NEWSWIRE) -- Los Angeles, California /GLOBENEWSWIRE/- April 8, 2020 -KRONOS ADVANCED TECHNOLOGIES, Inc., (OTC:KNOS) ("KNOS" or the "Company") a proprietary product development and production company that has significantly changed the way air is moved, filtered and sterilized announced today it has secured exclusive North and South American production and distribution rights for an air purification and disease destruction product line that utilizes the Kronos(R) CORE technology that has been developed by Kronos to produce, market and distribute commercial and residential air purification products, bacteriological and virus destruction devices. The agreement provides Kronos with the exclusive license to manufacture, use and sell these products in the Americas. The first products are scheduled to launch this month with some already available via http://www.shop.kronosati.co

These products are being marketed under trademarks, KRONOS® AIR 5G® and AIRDOG®

The Manufacturer has historically worked with Dr. V. Gorobets, PHD, who now leads Kronos R&D on the development of a portfolio of standalone air purification products for the health care, residential and hospitality markets. The Company is planning to apply to the FDA in order to achieve product certification for use of these products in medical facilities.

The Company’s marketing efforts will focus on government entities, including state and federal hospitals, medical offices and research laboratories as well as residential markets.

"The results obtained in prior tests make it possible to recommend with a high degree of confidence that the Kronos CORE technology built devices can be used in hospitals dealing with infectious diseases and in clinical and diagnostic laboratories which diagnose infectious diseases, after obtaining the FDA clearance," stated Dr V. Gorobets.

"In the times of a global pandemic, there is a great need for the specialized air disinfection in medical institutions where there are a lot of bed-ridden patients and patients with serious conditions in hospices, nursing homes and assisted living facilities."

“Our new products will allow the air quality in the hospitals to comply with the latest sanitary and hygienic State and Federal requirements in terms of pathogenic microorganisms content in the air,”-added Mr. Julius Toth, Company’s COO.

"We are pleased to have signed this Exclusive Manufacturing and Distribution agreement and we believe this is currently our best channel to leverage and extend our leading capabilities in Air purification and disinfection technology development into the world of the Indoor Air Quality (IAQ) markets," said Michael Rubinov, President. "With Kronos’ reputation and position in the market we are looking forward to the opportunity to apply our expertise in innovative ways to solve real-time needs."